Optum Health

Lake Success, New York 11042

1 studies enrolling now · 2 studies all time

What they study most

Early Breast Cancer, Primary Immune Thrombocytopenia (ITP)

Studies at this site

• Phase IIIb Study of Ribociclib + ET in Early Breast Cancer — Recruiting now
• Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP) — Running, not enrolling